alkenes has been researched along with Acute Promyelocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, H; Ishii, H; Koyama, H; Sumi, K; Suzuki, M; Takashima-Hirano, M; Watanabe, C | 1 |
| Darzynkiewicz, Z; Del Bino, G; Hotz, MA; Lassota, P; Traganos, F | 1 |
2 other study(ies) available for alkenes and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Synthesis of (11)C-labeled retinoic acid, [(11)C]ATRA, via an alkenylboron precursor by Pd(0)-mediated rapid C-[(11)C]methylation.
Topics: Alkenes; Antineoplastic Agents; Boron Compounds; Carbon Isotopes; Catalysis; Contrast Media; Humans; Leukemia, Promyelocytic, Acute; Methylation; Palladium; Positron-Emission Tomography; Tretinoin | 2014 |
Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
Topics: Alkenes; Amsacrine; Antibiotics, Antineoplastic; Cell Cycle; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Leukemia, Promyelocytic, Acute; Polyenes; Pyrones; Teniposide; Tumor Cells, Cultured | 1992 |